Global E-Cigarette Market Growth Trends and Predictions in 2029

Feb.08.2025
Global E-Cigarette Market Growth Trends and Predictions in 2029
E-cigarette market projected to grow from $189.8 billion to $231.5 billion by 2029, with rechargeable types leading.

According to a report by Tobacco Reporter on January 15, the recently released E-Cigarette Market Research Report 2020-2029 predicts that the e-cigarette market is expected to grow from its current value of $18.98 billion to $23.15 billion by 2029, representing a growth rate of 3.4%.


In terms of product types, in 2023, rechargeable e-cigarettes have dominated the global e-cigarette market. Compared to disposable e-cigarettes, rechargeable e-cigarettes are more environmentally friendly. Additionally, in the long run, rechargeable e-cigarettes are usually more cost-effective. In terms of flavor types, in 2023, non-tobacco flavor e-cigarettes have taken the lead in the global market. The global demand for non-tobacco flavor e-cigarettes is driven by various factors including their appeal to young users, desire for diversity and customization, and effective marketing strategies. In terms of distribution channels, the offline e-cigarette market has taken the lead in the global market in 2023. Brick-and-mortar stores including e-cigarette shops, convenience stores, and specialty retailers have unique advantages and will continue to drive demand for e-cigarettes through offline channels. North America, especially the United States, is one of the largest and most mature e-cigarette markets. The region has a high prevalence of e-cigarettes, increased health awareness, and strong consumer interest in smoking alternatives, all contributing to the popularity of e-cigarettes. In 2023, Europe accounted for over 51% of the global e-cigarette market revenue. The European market is highly diversified, with strong demand in countries such as the UK, France, and Germany. Additionally, North America holds a significant share in the global e-cigarette market. The Asia-Pacific region is the third largest regional market, led by countries such as China, Australia, and South Korea; despite regulatory barriers, the Latin America region still has huge growth potential due to accelerated urbanization, a young population, and increasing disposable income. As more countries in the Middle East and Africa consider revising their regulatory frameworks, the region is expected to witness increased market penetration and growth in the coming years.


The main participants in the global e-cigarette market include Altria (Altria Group), British American Tobacco (BAT), Imperial Brands (IMB), and Japan Tobacco International (JTI). With increasing awareness of health and growing regulatory pressure, sales of traditional cigarettes are gradually decreasing. These companies are actively entering the e-cigarette market, driving innovation and technological development.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI Launches Mass Production of ZYN at $600M Aurora Manufacturing Hub
PMI Launches Mass Production of ZYN at $600M Aurora Manufacturing Hub
Philip Morris International (PMI), through its subsidiary Swedish Match, has started large-scale production at a 600,000-square-foot ZYN nicotine pouch facility in Aurora, Colorado. The $600 million investment makes the site one of three ZYN manufacturing plants in the United States and the company’s second U.S. facility after Owensboro, Kentucky.
PMI
Feb.21
Syria announces comprehensive ban on e-cigarettes covering production, trade, sale and use
Syria announces comprehensive ban on e-cigarettes covering production, trade, sale and use
Syria Damascus health authorities announced a comprehensive ban on e-cigarettes, prohibiting their production, circulation, sale and use, citing health risks and the need to protect public health, particularly among children and young people.
Mar.02 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
From Tamarind’s AI Shift to Industry Restructuring, The ‘Amazon Moment’ for Nicotine Is Approaching
From Tamarind’s AI Shift to Industry Restructuring, The ‘Amazon Moment’ for Nicotine Is Approaching
Tamarind Intelligence’s decision to appoint a technology-sector executive as chief executive officer signals more than a leadership reshuffle at a specialist data firm. It reflects a broader structural shift across the global nicotine industry, where companies, regulators and intelligence providers are embedding artificial intelligence into core operations.
Special Report
Feb.18
U.S. FDA Posts Final ZYN MRTP Materials, Sets March 4 Deadline for Public Comments
U.S. FDA Posts Final ZYN MRTP Materials, Sets March 4 Deadline for Public Comments
U.S. FDA has released the final batch of materials for ZYN MRTP applications and set March 4 (11:59 p.m. ET) as the deadline for public comments to be considered in the agency’s review.
Feb.03 by 2FIRSTS.ai
JT Launches Limited-Edition Ploom AURA “Fuchsia Flare” in Advance Sales Starting March 10
JT Launches Limited-Edition Ploom AURA “Fuchsia Flare” in Advance Sales Starting March 10
Japan Tobacco Inc. (JT) began advance sales on March 10 for the fifth limited-edition color of its heated tobacco device “Ploom AURA,” named “Fuchsia Flare.” The product is available through the CLUB JT online shop and Ploom Shops nationwide at a price of JPY 2,980. From March 17, it will also be sold in limited quantities at convenience stores nationwide and selected tobacco retailers.
Mar.10 by 2FIRSTS.ai